FDA Approved: STOBOCLO — Original Application (CELLTRION USA, Inc.)

View source ↗

Summary

FDA approved STOBOCLO (denosumab-BMWO) from Celltrion USA as an original application; a denosumab biosimilar with indications including osteoporosis and cancer-…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases From Solid Tumors
• Hypercalcemia of Malignancy
• Osteoporosis

Drugs mentioned

• STOBOCLO (DENOSUMAB-BMWO)

Snippet

ORIG AP for STOBOCLO (DENOSUMAB-BMWO)